CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV and HCV), performed on the Tigris testing platform, to the -enhanced Ultrio Elite triplex assay performed on the Panther testing platform on July 13, 2020. The implementation date has been moved up to July 7th. Contact your Customer Service Manager if you have any questions!
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...